Nanotechnology Responses to COVID‐19

@article{RuizHitzky2020NanotechnologyRT,
  title={Nanotechnology Responses to COVID‐19},
  author={Eduardo Ruiz-Hitzky and Margarita Darder and Bernd Wicklein and Cristina Ruiz-Garcia and Raquel Mart{\'i}n-Sampedro and Gustavo Del Real and Pilar Aranda},
  journal={Advanced Healthcare Materials},
  year={2020},
  volume={9}
}
Researchers, engineers, and medical doctors are made aware of the severity of the COVID‐19 infection and act quickly against the coronavirus SARS‐CoV‐2 using a large variety of tools. In this review, a panoply of nanoscience and nanotechnology approaches show how these disciplines can help the medical, technical, and scientific communities to fight the pandemic, highlighting the development of nanomaterials for detection, sanitation, therapies, and vaccines. SARS‐CoV‐2, which can be regarded as… 
Insights from nanotechnology in COVID-19: prevention, detection, therapy and immunomodulation
TLDR
Overall, this review discusses various nanoformulations that have shown clinical relevance or can be explored in the fight against COVID-19 and highlights the nanoparticle-based vaccination approaches and how nanoparticles can regulate the host immune system against infection.
Use of Nanoparticles to Combat COVID-19
  • Ashish Kumar, A. Thakur
  • Biology, Medicine
    Handbook of Research on Green Synthesis and Applications of Nanomaterials
  • 2022
TLDR
This chapter focuses on nano-based diagnostics, accompanied by a study of nano- based therapeutics and treatments that have been shown to be effective against viruses that are closely related to SARS-CoV-2.
Nanoscience versus Viruses: The SARS‐CoV‐2 Case
TLDR
This review highlights how the incredible potential of nanoscience can be tapped by mimicking natures’ viruses for the development of maximally efficient pharmaceuticals, by designing preventive and protective equipment, e.g., face masks, as well as developing nanosensors for early detection of infections.
Recent Advances on Nanomaterials for Diagnostic, Treatment, and Prevention of COVID-19
  • R. Vargas-Bernal
  • Medicine
    Handbook of Research on Green Synthesis and Applications of Nanomaterials
  • 2022
TLDR
The role that nanomaterials are playing and that must be overcome due to the pandemic are described to guide readers on the innovations that are required related to the diagnosis, treatment, and prevention of SARS-CoV-2 and its variants.
Deciphering the role of nanostructured materials in the point-of-care diagnostics for COVID-19: a comprehensive review.
TLDR
The complete outline of the diagnostic platforms developed using nanoparticles in the detection of SARS-CoV-2 is presented, delineating the direct and indirect use of nanomaterials in COVID-19 diagnosis.
Unveiling the Potential Role of Nanozymes in Combating the COVID-19 Outbreak
TLDR
The utility and potential of nanozymes from the perspective of COVID-19 and future research directions and potential applications of nanoZymes are highlighted to overcome the challenges related to early diagnosis and therapeutics development for the SARS-CoV-2.
Nano‐therapeutic strategies to target coronavirus
TLDR
Potential therapeutics including human recombinant ACE2 soluble, inflammatory cytokine inhibitors, and direct anti‐viral agents such as remdesivir and favipiravir are discussed, to limit their fatality.
Polymeric nanoparticles as therapeutic agents against coronavirus disease
TLDR
The latest advancements in polymer-based nanotechnology approaches used to fight against SARS-CoV-2 are compiled and discussed and the importance of forefront in vitro technologies — such as 3D bioprinting and organ-on-chip — to evaluate the efficacy of nanotherapeutic agents is highlighted.
On the Efficacy of ZnO Nanostructures against SARS-CoV-2
TLDR
ZnO nanoparticles were produced using an ecofriendly method and fully characterized; their antiviral activity was tested in vitro against SARS-CoV-2, showing a decrease in viral load between 70% and 90%, as a function of the material’s composition.
...
...

References

SHOWING 1-10 OF 254 REFERENCES
Can Nanotechnology and Materials Science Help the Fight against SARS-CoV-2?
TLDR
The importance of nanomaterial-based technological solutions in several aspects of the fight against the virus is underlined, increasing the efficacy of personal protection equipment, developing synergistic antiviral coatings, are only two of the cases discussed.
Optimizing use of theranostic nanoparticles as a life-saving strategy for treating COVID-19 patients
TLDR
Light is shed on the promising role of nanoparticles as effective carriers for therapeutics or immune modulators to help in fighting against COVID-19.
The role of nanotechnology in the treatment of viral infections
TLDR
This review presents a broad overview of the application of nanosized materials for the treatment of common viral infections as well as potential candidates to explore in order to achieve and/or improve therapeutic effects.
Selective Naked-Eye Detection of SARS-CoV-2 Mediated by N Gene Targeted Antisense Oligonucleotide Capped Plasmonic Nanoparticles
TLDR
A colorimetric assay based on gold nanoparticles (AuNPs), when capped with suitably designed thiol-modified antisense oligonucleotides (ASOs) specific for N-gene (nucleocapsid phosphoprotein) of SARS-CoV-2, could be used for diagnosing positive COVID-19 cases within 10 min from the isolated RNA samples.
Nano Research for COVID-19
TLDR
A number of vaccine candidates are being repurposed against SARS-CoV-2, and some have recently entered phase I clinical trials; and researchers are examining different drug formulations to treat patients suffering with COVID-19.
Nanoparticle-Based Vaccines Against Respiratory Viruses
TLDR
An overview of the advantages associated with the use of nanoparticles as vaccine delivery platforms to immunize against respiratory viruses is provided and relevant examples demonstrating their potential as safe, effective and affordable vaccines are highlighted.
A SARS-CoV-2 Protein Interaction Map Reveals Targets for Drug-Repurposing
TLDR
A human–SARS-CoV-2 protein interaction map highlights cellular processes that are hijacked by the virus and that can be targeted by existing drugs, including inhibitors of mRNA translation and predicted regulators of the sigma receptors.
Macromolecular Antiviral Agents against Zika, Ebola, SARS, and Other Pathogenic Viruses
TLDR
This work performs selection of synthetic polymers as novel broadly active agents and demonstrates activity of these polymers against Zika, Ebola, Lassa, Lyssa, Rabies, Marburg, Ebola), influenza, herpes simplex, and human immunodeficiency viruses.
Design and Delivery of Therapeutic siRNAs: Application to MERS-Coronavirus.
TLDR
The efficacy of siRNA-based therapeutics has been used not only against many viral diseases but also against non-viral diseases, cancer, dominant genetic disorders, and autoimmune disease.
...
...